Spatial patterning during animal development is genetically controlled by genes such as the Hox cluster. Similarly, the temporal aspect of developmental patterning is under the genetic control of heterochronic genes. The most extensively investigated heterochronic pathway defines a somatic clock that controls the timing of cell fate determination during C. elegans post-embryonic development. Although a number of key heterochronic genes have been identified, the molecular mechanisms that underlie temporal control of cell division and proliferation remain elusive. The heterochronic gene
lin-42 is the C. elegans homolog of Drosophila and mammalian period , key regulators of circadian rhythms, which specify behavior and physiology over a 24 hour day/night cycle.
lin-42 thus defines a molecular link between two different types of biological clocks: developmetal timing and circadian timing. In addition to
lin-42 , the C. elegans genome contains homologs of a number of core circadian clock genes. We have investigated the possible function of these homologs in control of developmental timing by using RNA interference (RNAi) to knock-down gene expression. We describe the identification and characterization of two genes that interact with the developmental clock:
kin-20 (casein kinase I e /CKI e ) and
kin-19 (casein kinase I a/ CK Ia ), which are C. elegans homologs of Drosophila doubletime .
kin-19 / CK Ia and
kin-20/CKI e antagonistically regulate cell fate decisions during late larval development.
kin-19 is downstream of and negatively regulated by
kin-20 ,
lin-42,
lin-41 and
hbl-1, which either work together or in parallel. We have also found that the homologs to the Drosophila clock genes timeless , casein kinase II a , protein phosphatase 2A, vrille, and
pdp1 appear to function in the developmental clock. Our results, showing function of multiple circadian gene homologs in the developmental clock, suggest that circadian and developmental timing pathways may utilize conserved mechanisms of temporal regulation. Our work also suggests that one or more of the heterochronic genes already identified, including CK Ia and microRNAs, may play a role in circadian timing. Furthermore, our findings point to circadian genes being regulators of cell fate timing, and support reports that circadian genes can function as oncogenes in mammals.